New monoclonal antibody could be a game-changer in treating rare liver disease by reducing inflammation and fibrosis, says new study – The Times of India

New monoclonal antibody could be a game-changer in treating rare liver disease by reducing inflammation and fibrosis, says new study – The Times of India

A new monoclonal antibody called nebokitug offers fresh hope to patients who have primary sclerosing cholangitis (PSC), because this rare liver disease has limited treatment options until now, except for a transplant. The first set of trials, led by University of California-Davis, US, (Published in the American Journal of Gastroenterology) …

Read more

Junk food turns public villain as power shifts in Washington

Junk food turns public villain as power shifts in Washington

The new Trump administration could be coming for your snacks. For years, the federal government has steered clear of regulating junk food, fast food and ultra-processed food. Now attitudes are changing. Some members of President-elect Donald Trump’s inner circle are gearing up to battle “Big Food,” or the companies that …

Read more

FDA approves Merck’s drug for rare, deadly lung condition

FDA approves Merck’s drug for rare, deadly lung condition

The Food and Drug Administration on Tuesday approved a drug from Merck designed to treat a progressive and life-threatening lung condition in a win for both the drugmaker and for patients suffering from the rare disease. The agency greenlighted the therapy, which will be marketed as Winrevair, for adults with …

Read more